This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday
Author: Avi Kapoor | May 27, 2025 07:05am
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
HC Wainwright & Co. analyst Matthew Caufield downgraded Unity Biotechnology, Inc. (NASDAQ:UBX) from Buy to Neutral and lowered the price target from $4 to $2. Unity Biotechnology shares closed at $0.7790 on Friday. See how other analysts view this stock.
Wolfe Research analyst Timna Tanners downgraded United States Steel Corporation (NYSE:X) from Outperform to Peer Perform. United States Steel shares closed at $52.01 on Friday. See how other analysts view this stock.
BTIG analyst Ryan Zimmerman downgraded Globus Medical, Inc. (NYSE:GMED) from Buy to Neutral. Globus Medical shares closed at $58.96 on Friday. See how other analysts view this stock.
Considering buying X stock? Here’s what analysts think:
